Angiography Catheters Market is Segmented by product such as Cerebral Catheters, Visceral Catheters, Coronary Catheters, Renal Catheters, Microcatheters, Pigtail Catheters having application such as Coronary, Endovascular, Neurology, Oncology
Industry: Healthcare
Published Date: January-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 245
Report ID: PMRREP31549
The global revenue from the angiography catheters market was approximately US$ 1.4 Bn in 2022, with the global market expected to grow at a CAGR of 6.5% to reach a valuation of approximately US$ 2.7 Bn by the end of 2033.
|
Market Size (2023) |
US$ 1.5 Bn |
|
Projected Market Value (2033) |
US$ 2.7 Bn |
|
Global Market Growth Rate (2023-2033) |
6.5% CAGR |
|
Market Share of Top 5 Countries |
57.5% |
As assessed by Persistence Market Research, coronary catheters held a market share of around 53.2% in the global market, in 2022. Overall, angiography catheters market sales account for approximately 6.9% revenue share in the global catheters market, which was valued at around US$ 19.9 Bn in 2022.
The global market recorded a historic CAGR of 6.2% in the last 7 years from 2015 to 2022.
Through the development of more precise diagnostic techniques as well as more efficient and minimally invasive therapeutic methods, cardiology has completely changed the way diseases are managed. The operations carried out in the hemodynamic labs of cardiology referral facilities are important for the identification and management of cardiovascular disorders. Coronary angiography is among the most popular hemodynamic procedures.
The angiographic catheter is a key piece of medical equipment used for percutaneous angiography. These thin, flexible tubes are made of various materials, such as polyamide, polyurethane, and Teflon.
The key growth factors for the angiographic catheters market are the rising adoption of minimally invasive procedures, rising incidence of cardiovascular diseases, increasing demand for definitive diagnosis, and growing awareness of various diseases such as cardiovascular diseases.
The WHO estimates that 17.9 million people globally die from cardiovascular diseases (CVDs), which are the primary cause of mortality. One American dies of cardiovascular disease every 34 seconds, according to the US Centers for Disease Control and Prevention. One of every five deaths in the United States in 2020 were caused by heart disease, which claimed about 697,000 lives.
Hospitalization is becoming more and more necessary due to the rising frequency of chronic diseases such those affecting the endocrine, cardiovascular, renal, and urological systems. The market is expanding because patients with such chronic diseases need to undergo some level of catheterization to clear an arterial blockage.
Additionally, rising elderly population and rise in vascular syndrome cases brought on by obesity, hypertension, and sedentary lifestyle are boosting the market for angiographic catheters.
The global market is thus likely to show high growth over the coming years at a CAGR of 6.5% and reach a global market size of US$ 2.7 Bn by 2033.
“Development of Magnetic Resonance Angiography, and Tapping Emerging Markets”
There is a global increase in market consolidation measures like capacity growth or the establishment of new manufacturing facilities. Manufacturing, research and development, mergers and acquisitions, and service contracts will help to significantly increase market potential.
Improvements in catheterization procedures can significantly affect the dependability and viability of angiography catheters for the purpose for which they are intended.
Prominent manufacturers who want to widen the market for their products and their distribution network may consider investing in emerging markets in these countries.
Global manufacturers need to place a high priority on exploring untapped areas in emerging economies like Asia and Latin America in order to boost their angiography catheters product services and market income.
The use of non-invasive procedures utilising CT and magnetic resonance imaging technologies has been added to the scope of angiography because of advances in imaging technology during the past three decades. Particularly in this time of rapid advancements in imaging technologies, the clinical uses of magnetic resonance angiography have grown more important for the patient and the practitioner.
These advancements are set to propel the global market over the forecast period.
“High Procedure Cost, Catheter Associated Limitations, and Stringent Regulatory Requirements”
In both industrialised and developing nations, cardiovascular illnesses account for a significant portion of morbidity and death. More than a million coronary artery procedures are reportedly performed each year, at a considerable cost to society. Angiograms and angioplasty of the coronary arteries are the most frequently performed procedures.
The most frequent side effects from cardiac catheterization procedures include hematoma and retroperitoneal bleeding. Hematomas typically develop after post-sheath removal haemostasis that is not well maintained.
The availability of alternative therapies and the high cost of the angiographic process are anticipated to restrain the growth of the global market.
The global market for angiographic catheters is constrained in its expansion by the availability of alternative therapies and problems related to angiographic catheters.
The main obstacles to the expansion of the angiographic catheters market are the strict regulatory requirements, high procedure costs, the availability of alternative treatments such drugs, and complications, as well as a shortage of qualified practitioners.
Companies who are manufacturing angiographic catheters are needed to uphold strict regulatory criteria on a global scale. A significant obstacle to the entry of new players is the high level of capital requirement. The established businesses now have a competitive advantage in maintaining their market share.
Why is the U.S. Market Booming?
“Growing Cardiovascular Disease Incidence Indicating Greater Procedural Uptake”
The U.S. accounted for around 92.0% market share in the North America market in 2022.
The rise in the prevalence of cardiovascular disorders, the expansion of diagnostic and imaging centers, and heightened awareness of minimally invasive techniques are all factors contributing to the market's expansion in the United States. According to the CDC, coronary artery disease (CAD) was the leading cause of death in the US in 2021.
The need for percutaneous coronary intervention, angioplasty, and cardiac catheterization is expected to increase, as there is an increase in CVD cases around the world. For these procedures, cardiac catheters and guidewires are essential.
The rising cardiovascular disease incidence in the country is set to propel the market for angiography catheters in the region, during the forecast period.
Will Germany Be a Lucrative Market for Angiography Catheters?
“Presence of Procedural Reimbursement, and Growth in Medical Tourism Industry”
Germany held around 29.1% market share of the Europe market in 2022.
Germany continues to hold the largest market share in Europe for angiographic catheters as a result of the expanding government reimbursement programmes for persons having coronary angioplasty. The German healthcare sector has been propelled by medical tourism initiatives.
The market in Germany is expected to grow over the projected period because of an increase in the number of overseas patients receiving common cardiac catheterization procedures in the nation.
How is Japan Emerging as a Prominent Market?
“Rising Cases of Cardiac Surgical Interventions”
Japan held a market share of about 58.6% of the East Asia market in 2022.
The market in Japan is set to expand over the forecast period. Factors propelling this growth include the presence of a vast geriatric population, growth in the healthcare structure, presence of key players in the market, such as, Canon Medical, and the presence of a wide distribution channel catering to foreign consumers.
With the rising ageing population in the country, the risk of age related issues such as diabetes and hypertension increases. With increasing risk of cardiovascular comorbidities, the ageing population contributes to the growth and adoption of angiography catheters, owed to a rise in the number of cardiac surgical procedures.
In 2018, the Japanese Association for Thoracic Surgery carried out its yearly surveys of thoracic surgery around Japan. The data showed that 20,746 surgeries for thoracic aortic aneurysms were conducted in Japan in 2018, up from 21,624 treatments in 2017. This represents an increase of 96.6% from the prior year.
Increasing rate of cardiac interventions are expected to drive the market in Japan.
Which Product is Driving Demand within the Global Market?
“Growing Prevalence of Cardiovascular Diseases Propelling Product Uptake”
The coronary catheters segment held around 53.2% share of the total market in 2022.
Cardiac catheterization is a routine technique used to identify or treat a number of cardiac conditions. It is applied in the identification or treatment of certain heart disorders, such as blocked arteries or irregular heartbeats, by directing a thin, catheter through a blood channel to the heart. Coronary angiography and cardiac catheterization can provide crucial information about the heart and the external blood vessels that supply it.
This can help in heart disease diagnosis, planning prospective therapies, and carrying out particular procedures. With increasing global prevalence of cardiovascular diseases, the segment is expected to grow in value, over the forecast period.
Which Application is Widely in Focus in the Global Market?
“Increasing Patient Pool, Globally”
Coronary applications hold a share of about 54.2% in 2022, globally.
An invasive imaging procedure called a coronary angiography enables a medical professional to assess the patient's heart health. The medical professional inserts a catheter first into an arm or groin blood vessel, then into the coronary arteries. Heart catheterizations are occasionally used in conjunction with other procedures to diagnose abnormalities and address them.
With rising risk of heart diseases worldwide, as well as the increasing incidence of chronic diseases such as diabetes and hypertension, the segment is expected to be propelled by the increasing number of patients with cardiac ailments.
Which End User Propels the Global Sales in the Market?
“Rising Burden of Chronic Disease and Large Inpatient Volumes”
Hospitals hold a share of about 65.6% in 2022, within the global market. The global prevalence of heart diseases is rising. This is associated with the increasing prevalence of chronic diseases, as well as lifestyle modifications. Hospital settings provide comprehensive patient diagnosis, as well as treatment regimen. With the availability of cardiac medical devices in institutional settings, the adoption of minimally invasive procedures in on the rise, thus propelling the share of the hospital segment in the global market.
The key manufacturers are constantly innovating and developing new products to maintain their leading position within the angiographic catheters market. They are also focused on increasing their revenue share, which is essential for sustaining their position in the market. These companies have a wide product portfolio that encompasses comprehensive features, making them well equipped to compete in the global market.
Their distribution network is widespread, which allows them to serve customers in a variety of regions.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the angiography catheters market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2015-2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Application:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 1.4 Bn in 2022.
Sales of the market are set to witness growth at a CAGR of 6.5% and be valued at around US$ 2.7 Bn by 2033.
Demand for the global market increased at a 6.2% CAGR from 2015 to 2022.
The U.S., Japan, Germany, U.K., and France account for most demand within the market, currently holding around 57.5% market share.
The U.S. accounts for around 92.0% share of the North American market in 2022.
Latin America accounts for around 6.7% share of the global market in 2022.
The China market held a share of about 29.6% in the East Asia angiography catheters market in 2022, while Japan accounts for around 58.6% share.
The Germany angiography catheters market is set to expand at 6.7% CAGR over the forecast period.
The Brazil angiography catheters market is expected to grow at a 5.5% CAGR during the forecast period.
The angiography catheters market in India is set to expand at a 7.7% CAGR over the forecast period.
